These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15640644)

  • 1. Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU.
    Pankhaniya RR; Tamura M; Allmond LR; Moriyama K; Ajayi T; Wiener-Kronish JP; Sawa T
    Crit Care Med; 2004 Nov; 32(11):2293-9. PubMed ID: 15640644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of the phospholipase catalytic domain of the Pseudomonas aeruginosa cytotoxin ExoU abolishes colonization promoting activity and reduces corneal disease severity.
    Tam C; Lewis SE; Li WY; Lee E; Evans DJ; Fleiszig SM
    Exp Eye Res; 2007 Dec; 85(6):799-805. PubMed ID: 17905228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophospholipase A activity of Pseudomonas aeruginosa type III secretory toxin ExoU.
    Tamura M; Ajayi T; Allmond LR; Moriyama K; Wiener-Kronish JP; Sawa T
    Biochem Biophys Res Commun; 2004 Apr; 316(2):323-31. PubMed ID: 15020221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.
    Finck-Barbançon V; Goranson J; Zhu L; Sawa T; Wiener-Kronish JP; Fleiszig SM; Wu C; Mende-Mueller L; Frank DW
    Mol Microbiol; 1997 Aug; 25(3):547-57. PubMed ID: 9302017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread.
    Allewelt M; Coleman FT; Grout M; Priebe GP; Pier GB
    Infect Immun; 2000 Jul; 68(7):3998-4004. PubMed ID: 10858214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa toxin ExoU induces a PAF-dependent impairment of alveolar fibrin turnover secondary to enhanced activation of coagulation and increased expression of plasminogen activator inhibitor-1 in the course of mice pneumosepsis.
    Machado GB; de Oliveira AV; Saliba AM; de Lima CD; Suassuna JH; Plotkowski MC
    Respir Res; 2011 Aug; 12(1):104. PubMed ID: 21819560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review.
    Sawa T; Shimizu M; Moriyama K; Wiener-Kronish JP
    Crit Care; 2014 Dec; 18(6):668. PubMed ID: 25672496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ExoU-induced vascular hyperpermeability and platelet activation in the course of experimental Pseudomonas aeruginosa pneumosepsis.
    Machado GB; de Assis MC; Leão R; Saliba AM; Silva MC; Suassuna JH; de Oliveira AV; Plotkowski MC
    Shock; 2010 Mar; 33(3):315-21. PubMed ID: 19543153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins.
    Faure K; Sawa T; Ajayi T; Fujimoto J; Moriyama K; Shime N; Wiener-Kronish JP
    Respir Res; 2004 Feb; 5(1):1. PubMed ID: 15040820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the membrane localization domain of the Pseudomonas aeruginosa effector protein ExoU in cytotoxicity.
    Veesenmeyer JL; Howell H; Halavaty AS; Ahrens S; Anderson WF; Hauser AR
    Infect Immun; 2010 Aug; 78(8):3346-57. PubMed ID: 20479080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type III secretion of ExoU is critical during early Pseudomonas aeruginosa pneumonia.
    Howell HA; Logan LK; Hauser AR
    mBio; 2013 Mar; 4(2):e00032-13. PubMed ID: 23481600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional regions of the Pseudomonas aeruginosa cytotoxin ExoU.
    Rabin SD; Hauser AR
    Infect Immun; 2005 Jan; 73(1):573-82. PubMed ID: 15618197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU.
    Sato H; Frank DW; Hillard CJ; Feix JB; Pankhaniya RR; Moriyama K; Finck-Barbançon V; Buchaklian A; Lei M; Long RM; Wiener-Kronish J; Sawa T
    EMBO J; 2003 Jun; 22(12):2959-69. PubMed ID: 12805211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ExoU-induced procoagulant activity in Pseudomonas aeruginosa-infected airway cells.
    Plotkowski MC; Feliciano LF; Machado GB; Cunha LG; Freitas C; Saliba AM; de Assis MC
    Eur Respir J; 2008 Dec; 32(6):1591-8. PubMed ID: 18684846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ExoU-induced redox imbalance and oxidative stress in airway epithelial cells during Pseudomonas aeruginosa pneumosepsis.
    da Cunha LG; Ferreira MF; de Moraes JA; Reis PA; Castro-Faria-Neto HC; Barja-Fidalgo C; Plotkowski MC; Saliba AM
    Med Microbiol Immunol; 2015 Dec; 204(6):673-80. PubMed ID: 25904542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors.
    Phillips RM; Six DA; Dennis EA; Ghosh P
    J Biol Chem; 2003 Oct; 278(42):41326-32. PubMed ID: 12915403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU.
    Saliba AM; Nascimento DO; Silva MC; Assis MC; Gayer CR; Raymond B; Coelho MG; Marques EA; Touqui L; Albano RM; Lopes UG; Paiva DD; Bozza PT; Plotkowski MC
    Cell Microbiol; 2005 Dec; 7(12):1811-22. PubMed ID: 16309466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IV Immunoglobulin for Acute Lung Injury and Bacteremia in Pseudomonas aeruginosa Pneumonia.
    Katoh H; Yasumoto H; Shimizu M; Hamaoka S; Kinoshita M; Akiyama K; Sawa T
    Crit Care Med; 2016 Jan; 44(1):e12-24. PubMed ID: 26317571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung.
    Shaver CM; Hauser AR
    Infect Immun; 2004 Dec; 72(12):6969-77. PubMed ID: 15557619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of the platelet activating factor signaling pathway to cerebral microcirculatory dysfunction during experimental sepsis by ExoU producing Pseudomonas aeruginosa.
    Plotkowski MC; Estato V; Santos SA; da Silva MC; Miranda AS; de Miranda PE; Pinho V; Tibiriça E; Morandi V; Teixeira MM; Vianna A; Saliba AM
    Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26187894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.